STAT

Opinion: More female leaders will help drive innovation in the medtech and biotech industries

I’m proud to be the executive vice president of a medical device company I co-founded 16 years ago. I love my industry and the innovative changes it creates that improve people’s lives around the world.

And yet I’m dismayed to see how few female executives there are in the medtech and biotech industries — roughly 1 for every 4 male executives and senior officers. That imbalance is bad for women and the future of these industries, because women make up half of the population and represent more than half of health care consumers.

Despite positive changes in

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks